ImmunoGen, Inc.
ImmunoGen, Inc. (IMGN) Stock Overview
Explore ImmunoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8.7B
P/E Ratio
-35.54
EPS (TTM)
$-0.28
ROE
-0.93%
IMGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ImmunoGen, Inc. (IMGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $61.31.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.54 and a market capitalization of 8.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.